| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.052 | 0.7 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |